Novo Nordisk - ADR
NVO
historical activity
Quarter | Shares | +/- Shares | Change % | Value($) | % of Total value | Avg Report Price($) |
---|---|---|---|---|---|---|
Q3 2023 | 2.1M | +1.1M | ↑100.00% | 195.5B | 2.36% | 90940.00 |
Q2 2023 | 1.1M | = | = | 174.0B | 2.07% | 161830.00 |
Q1 2023 | 1.1M | = | = | 171.1B | 2.17% | 159140.00 |
Q4 2022 | 1.1M | = | = | 145.5B | 1.95% | 135340.00 |
Q3 2022 | 1.1M | = | = | 107.1M | 1.58% | 99.63 |
Q2 2022 | 1.1M | = | = | 119.8M | 1.71% | 111.43 |
Q1 2022 | 1.1M | = | = | 119.4M | 1.41% | 111.05 |
Q4 2021 | 1.1M | = | = | 120.4M | 1.37% | 112.00 |
Q3 2021 | 1.1M | = | = | 103.2M | 1.3% | 96.01 |
Q2 2021 | 1.1M | = | = | 90.1M | 1.13% | 83.77 |
Q1 2021 | 1.1M | = | = | 72.5M | 1% | 67.42 |
Q4 2020 | 1.1M | = | = | 75.1M | 1.11% | 69.85 |